Leadership & Pay ·
Olema Pharmaceuticals appointed Jason O’Byrne as Chief Financial Officer, effective August 11, 2026
OLMAOlema Pharmaceuticals, Inc.
Olema Pharmaceuticals appointed Jason O’Byrne as Chief Financial Officer, effective August 11, 2026. Mr. O’Byrne brings prior executive finance experience from Vir Biotechnology and Caribou Biosciences. His compensation includes a $545,000 annual base salary, a target bonus of 45% of base, and a $350,000 sign-on bonus paid in two installments. He also received an inducement option to purchase 650,000 shares vesting over four years. Olema is a clinical-stage biopharmaceutical company focused on discovering and developing targeted therapies for breast cancer.